GROUP ONE TRADING, L.P. - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 106 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is 2.19 and the average weighting 0.8%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q2 2023$31,764
-18.9%
3,069
-15.0%
0.00%
Q1 2023$39,190
+5.9%
3,612
+0.1%
0.00%
Q3 2022$37,000
+146.7%
3,608
+115.4%
0.00%
Q2 2022$15,000
-81.9%
1,675
-80.7%
0.00%
Q1 2022$83,000
-83.3%
8,675
-80.7%
0.00%
Q4 2021$497,000
+3.3%
45,005
-30.8%
0.00%
-100.0%
Q3 2021$481,000
+2906.2%
65,058
+10113.2%
0.00%
Q4 2019$16,000
-95.1%
637
-96.2%
0.00%
-100.0%
Q3 2019$326,000
-66.5%
16,737
-71.9%
0.00%
-66.7%
Q2 2019$973,000
+271.4%
59,568
+414.5%
0.01%
+200.0%
Q1 2019$262,000
+870.4%
11,577
+952.5%
0.00%
Q1 2018$27,000
-77.5%
1,100
-68.6%
0.00%
-100.0%
Q3 2017$120,000
+140.0%
3,500
+154.2%
0.00%0.0%
Q3 2016$50,000
-9.1%
1,377
-52.7%
0.00%0.0%
Q1 2016$55,000
-5.2%
2,912
-17.1%
0.00%0.0%
Q4 2015$58,000
-88.8%
3,512
-92.6%
0.00%
-85.7%
Q3 2015$520,000
+5100.0%
47,284
+8038.4%
0.01%
Q1 2015$10,000
-79.2%
581
-72.2%
0.00%
-100.0%
Q3 2014$48,000
-57.1%
2,093
-40.6%
0.00%
-50.0%
Q2 2014$112,0003,5210.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Madison Avenue Partners, LP 8,511,350$72,176,2489.12%
Newtyn Management, LLC 2,124,703$18,017,4813.38%
Irenic Capital Management LP 2,760,948$23,412,8392.86%
Weiss Asset Management LP 7,457,060$63,235,8692.39%
Oasis Management Co Ltd. 1,157,965$9,819,5432.21%
Park West Asset Management LLC 1,700,000$14,416,0001.06%
Baupost Group 4,200,021$35,6160.98%
Camber Capital Management LP 1,000,000$8,4800.24%
Virtus ETF Advisers LLC 38,386$325,5130.16%
GSA CAPITAL PARTNERS LLP 204,089$1,7310.12%
View complete list of THERAVANCE BIOPHARMA INC shareholders